Jefferies Group LLC Aurinia Pharmaceuticals Inc. Call Options Transaction History

Jefferies Group LLC

  • $10.2 Billion
  • Q3 2022

Call Options

5 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$8.95 - $12.8 $134,250 - $192,000
-15,000 Closed
0 $0
Q1 2022

Sep 21, 2023
BUY
$10.05 - $22.48 $150,750 - $337,200
15,000 New
15,000 $185,000
Q1 2022

May 16, 2022
SELL
$10.05 - $22.48 $1.21 Million - $2.7 Million
-120,000 Reduced 88.89%
15,000 $186,000
Q1 2020

May 15, 2020
SELL
$11.34 - $21.46 $357,210 - $675,990
-31,500 Reduced 18.92%
135,000 $1.96 Million
Q4 2019

Feb 13, 2020
BUY
$3.88 - $21.42 $646,020 - $3.57 Million
166,500 New
166,500 $3.37 Million

Others Institutions Holding AUPH

# of Institutions
210
Shares Held
58.1M
Call Options Held
1.14M
Put Options Held
1.51M
View Full List

About Aurinia Pharmaceuticals Inc.

AUPH Quotes by TradingView
  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.13B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Jefferies Group LLC Portfolio

Follow Jefferies Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email